<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Consilium Medicum</journal-id><journal-title-group><journal-title xml:lang="en">Consilium Medicum</journal-title><trans-title-group xml:lang="ru"><trans-title>Consilium Medicum</trans-title></trans-title-group><trans-title-group xml:lang="zh"><trans-title>Consilium Medicum</trans-title></trans-title-group></journal-title-group><issn publication-format="print">2075-1753</issn><issn publication-format="electronic">2542-2170</issn><publisher><publisher-name xml:lang="en">Consilium Medicum</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">91411</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>Articles</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>Статьи</subject></subj-group><subj-group subj-group-type="article-type"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">Beta-adrenoblokatory v lechenii ostrykh koronarnykh sindromov (ili nuzhno li dokazyvat' dokazannoe?)</article-title><trans-title-group xml:lang="ru"><trans-title>Бета-адреноблокаторы в лечении острых коронарных синдромов (или нужно ли доказывать доказанное?)</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Shalaev</surname><given-names>S. V</given-names></name><name xml:lang="ru"><surname>Шалаев</surname><given-names>С. В</given-names></name></name-alternatives><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en"></institution></aff><aff><institution xml:lang="ru">Тюменский кардиологический центр - филиал НИИ кардиологии Томского научного центра СО РАМН</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2001-10-15" publication-format="electronic"><day>15</day><month>10</month><year>2001</year></pub-date><volume>3</volume><issue>10</issue><issue-title xml:lang="en">VOL 3, NO10 (2001)</issue-title><issue-title xml:lang="ru">ТОМ 3, №10 (2001)</issue-title><fpage>469</fpage><lpage>472</lpage><history><date date-type="received" iso-8601-date="2021-12-28"><day>28</day><month>12</month><year>2021</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2001, Consilium Medicum</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2001, ООО "Консилиум Медикум"</copyright-statement><copyright-year>2001</copyright-year><copyright-holder xml:lang="en">Consilium Medicum</copyright-holder><copyright-holder xml:lang="ru">ООО "Консилиум Медикум"</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://creativecommons.org/licenses/by-nc-sa/4.0</ali:license_ref></license></permissions><self-uri xlink:href="https://consilium.orscience.ru/2075-1753/article/view/91411">https://consilium.orscience.ru/2075-1753/article/view/91411</self-uri><abstract xml:lang="ru"><p>Сегодня практически не существует исследований по внутривенным бета-АБ (а именно этот способ применения может обсуждаться в подобной ситуации) в период догоспитальной помощи больным ОКС. Тем не менее бета-АБ могут назначаться в тех случаях, когда у больных с ОКС имеются традиционные показания - тахиаритмии, высокое артериальное давление (АД). Именно этими показаниями ограничена сфера применения бета-АБ в рекомендациях Европейского общества кардиологов ЕОК. Проведенные многочисленные исследования по применению бета-АБ при остро развившейся ишемии еще раз доказали доказанное - бета-АБ действительно, помимо прочих достоинств, являются превосходными противоишемическими средствами.</p></abstract></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>The Task Force on the management of acute myocardial infarction of the European Society of Cardiology. Acute myocardial infarction: pre - hospital and in - hospital management. Eur Heart J 1996; 17: 43-63.</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>1999 Update: ACC/AHA Guidelines for the management of patients with аcute myocardial infarction: executive summary and recommendations. A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (Committee on the management of acute myocardial infarctio). Circulation 1999; 100: 1016-30.</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>ACC/AHA Guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (Committee on the management of patients with unstable angina). JACC 2000; 36: 970-1062.</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>The pre - hospital management of acute heart attacks. Recommendations of the Task Force of the European Society of Cardiology and the European Resuscitationn Council. Eur Heart J 1998; 19: 1140-64.</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Yusuf S, Peto R, Lewis J. et al. Prog Cardiovasc Dis 1985; 27: 335-71.</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Roberts R, Rogers W.J, Mueller H.S. et al. Circulation 1991; 83: 422-37.</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Pfisterer M, Cox J.L, Granger C.B. et al. JACC 1998; 32: 634-40.</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Метелица В.И. Справочник по клинической фармакологии сердечно - сосудистых средств. М.: Медпрактика, 1996; 784.</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Barbier G.H, Shettigar U.R, Appunn D.O. Int J Clin Pharmacol 1995; 33: 212-8.</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Mooss A.N, Hilleman D.E, Mohiuddin S.M. et al. Ann Pharmacother 1994; 28: 701-3.</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Hohnloser S.H, Meinertz T, Klingenheben T. et al. Amer J Сardiol 1991; 67: 1319-23.</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Management of acute coronary syndromes: acute coronary syndromes without persistent ST segment elevation. Recommendations of the Task Force of the European Society of Cardiology. Eur Heart J 2000; 21: 1406-32.</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Kumar K.P, Krishnaswami S, Prasad N.K. et al. Indian Heart J 1989; 41: 240-4.</mixed-citation></ref></ref-list></back></article>
